48% of people are either hypertensive or at risk of becoming hypertensive & 30% of people have a high Waist Hip Ratio (WHR) – an early indication of the onset of CVDs
Arctoris and Evariste Technologies announce a joint venture to develop novel small molecule kinase inhibitors for non-small cell lung cancer (NSCLC)
The guidance also urges companies to act quickly to initiate a recall when public health is at risk and to do so prior to completing an investigation into the cause of the problem
Serina has over 17 years of experience in the biopharmaceutical industry
First of its kind integrated Heart Health Programme on its Health Station ‘hPod’
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
Acute therapies continue to report strong growth compared to chronic ones.
A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges
Subscribe To Our Newsletter & Stay Updated
